339 related articles for article (PubMed ID: 18226617)
21. Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia.
Lim JH; Kim SY; Park SY; Lee MH; Yang JH; Kim MY; Chung JH; Lee SW; Ryu HM
Prenat Diagn; 2009 May; 29(5):471-6. PubMed ID: 19253312
[TBL] [Abstract][Full Text] [Related]
22. Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.
Ohkuchi A; Hirashima C; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
Hypertens Pregnancy; 2009 Feb; 28(1):95-108. PubMed ID: 19165674
[TBL] [Abstract][Full Text] [Related]
23. Maternal serum soluble endoglin at 30-33 weeks in the prediction of preeclampsia.
Lai J; Syngelaki A; Poon LC; Nucci M; Nicolaides KH
Fetal Diagn Ther; 2013; 33(3):149-55. PubMed ID: 23154616
[TBL] [Abstract][Full Text] [Related]
24. First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.
Bian Z; Shixia C; Duan T
PLoS One; 2015; 10(4):e0124684. PubMed ID: 25906026
[TBL] [Abstract][Full Text] [Related]
25. Failure of second-trimester measurement of soluble endoglin and other angiogenic factors to predict placental abruption.
Tikkanen M; Stenman UH; Nuutila M; Paavonen J; Hiilesmaa V; Ylikorkala O
Prenat Diagn; 2007 Dec; 27(12):1143-6. PubMed ID: 17960788
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia.
Sandrim VC; Palei AC; Metzger IF; Gomes VA; Cavalli RC; Tanus-Santos JE
Hypertension; 2008 Aug; 52(2):402-7. PubMed ID: 18574068
[TBL] [Abstract][Full Text] [Related]
27. Uterine artery Doppler and mid-trimester maternal plasma homocysteine in subsequent pre-eclampsia.
Yu CK; Lakasing L; Papageorghiou AT; Spencer K; Nicolaides KH
J Matern Fetal Neonatal Med; 2004 Aug; 16(2):134-9. PubMed ID: 15512726
[TBL] [Abstract][Full Text] [Related]
28. Combination of plasma-soluble fms-like tyrosine kinase 1 and uterine artery Doppler for the prediction of preeclampsia in cases of elderly gravida.
Kulmala L; Phupong V
Hypertens Res; 2014 Jun; 37(6):538-42. PubMed ID: 24621465
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction.
Crispi F; Llurba E; Domínguez C; Martín-Gallán P; Cabero L; Gratacós E
Ultrasound Obstet Gynecol; 2008 Mar; 31(3):303-9. PubMed ID: 18058842
[TBL] [Abstract][Full Text] [Related]
30. Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry.
Diab AE; El-Behery MM; Ebrahiem MA; Shehata AE
Int J Gynaecol Obstet; 2008 Aug; 102(2):146-51. PubMed ID: 18423468
[TBL] [Abstract][Full Text] [Related]
31. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
[TBL] [Abstract][Full Text] [Related]
32. [Serum soluble Endoglin, plasma endothelin-1 and coagulation function in early onset severe preeclampsia with organ dysfunction].
Zhang LJ; Han YH; Han YZ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Jun; 22(6):371-4. PubMed ID: 20594474
[TBL] [Abstract][Full Text] [Related]
33. Angiogenic factors and preeclampsia.
Tjoa ML; Levine RJ; Karumanchi SA
Front Biosci; 2007 Jan; 12():2395-402. PubMed ID: 17127249
[TBL] [Abstract][Full Text] [Related]
34. Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations.
Chaiworapongsa T; Romero R; Kusanovic JP; Mittal P; Kim SK; Gotsch F; Than NG; Mazaki-Tovi S; Vaisbuch E; Erez O; Yeo L; Hassan SS; Sorokin Y
Ultrasound Obstet Gynecol; 2010 Feb; 35(2):155-62. PubMed ID: 20101637
[TBL] [Abstract][Full Text] [Related]
35. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.
Spencer K; Cowans NJ; Chefetz I; Tal J; Meiri H
Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788
[TBL] [Abstract][Full Text] [Related]
36. Angiogenic factors for prediction of preeclampsia and intrauterine growth restriction onset in high-risk women: AngioPred study.
Raia-Barjat T; Prieux C; Gris JC; Chapelle C; Laporte S; Chauleur C
J Matern Fetal Neonatal Med; 2019 Jan; 32(2):248-257. PubMed ID: 28889770
[TBL] [Abstract][Full Text] [Related]
37. Circulating soluble endoglin and placental abruption.
Signore C; Mills JL; Qian C; Yu KF; Rana S; Karumanchi SA; Levine RJ
Prenat Diagn; 2008 Sep; 28(9):852-8. PubMed ID: 18702104
[TBL] [Abstract][Full Text] [Related]
38. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
Levine RJ; Lam C; Qian C; Yu KF; Maynard SE; Sachs BP; Sibai BM; Epstein FH; Romero R; Thadhani R; Karumanchi SA;
N Engl J Med; 2006 Sep; 355(10):992-1005. PubMed ID: 16957146
[TBL] [Abstract][Full Text] [Related]
39. Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry.
Madazli R; Kuseyrioglu B; Uzun H; Uludag S; Ocak V
Int J Gynaecol Obstet; 2005 Jun; 89(3):251-7. PubMed ID: 15919391
[TBL] [Abstract][Full Text] [Related]
40. Early pregnancy screening for hypertensive disorders in women without a-priori high risk.
Abdelaziz A; Maher MA; Sayyed TM; Bazeed MF; Mohamed NS
Ultrasound Obstet Gynecol; 2012 Oct; 40(4):398-405. PubMed ID: 22689569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
